AtriCure, Inc. — insider transactions
12 transactions on record · CIK 1323885
Aggregates
computed from the filings belowPurchases, 12m
0
count of open-market buys
Sales, 12m
12
count of open-market sales
Buy / sell ratio, 12m
0.00
purchases per sale
Distinct insiders, 12m
8
Bought, 3m
$0
Sold, 3m
$3.3M
Median disclosure lag
2.0 d
trade date to filing date
Largest single trade, 24m
$946K
2026-07-28
Director share, 12m
58.3%
of transactions where role is stated
Current run
12 sells
consecutive same-direction transactions
Net 3m flow
-$3.3M
purchases minus sales
Total on record
12
Transactions
12 most recent shown| Disclosed | Traded | Lag, d | Insider | Role | Transaction | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-10 | 2026-09-08 | 2 | Privitera Salvatore | Chief Technical Officer | Open market sale | 3,657 | $55.00 | $201.1K | filing |
| 2026-09-04 | 2026-09-02 | 2 | Privitera Salvatore | Chief Technical Officer | Open market sale | 7,763 | $52.50 | $407.6K | filing |
| 2026-08-26 | 2026-08-24 | 2 | Dahlquist Karl S. | Chief Legal Officer | Open market sale | 9,370 | $48.89 | $458.1K | filing |
| 2026-08-07 | 2026-08-05 | 2 | Prange Karen | Director | Open market sale | 3,564 | $38.80 | $138.3K | filing |
| 2026-08-07 | 2026-08-05 | 2 | Yuen Maggie | Director | Open market sale | 3,500 | $38.42 | $134.5K | filing |
| 2026-08-03 | 2026-07-30 | 4 | CARREL MICHAEL H | Director, President, CEO, & Director | Gift | 4,000 | $0.00 | — | filing |
| 2026-08-03 | 2026-07-30 | 4 | CARREL MICHAEL H | Director, President, CEO, & Director | Gift | 700 | $0.00 | — | filing |
| 2026-07-30 | 2026-07-28 | 2 | WEHRWEIN SVEN | Director | Open market sale | 25,000 | $37.84 | $946K | filing |
| 2026-07-30 | 2026-07-28 | 2 | WEHRWEIN SVEN | Director | Exercise of derivative | 25,000 | $19.95 | $498.8K | filing |
| 2026-07-30 | 2026-07-28 | 2 | WEHRWEIN SVEN | Director | Exercise of derivative | 25,000 | $0.00 | — | filing |
| 2026-07-30 | 2026-07-29 | 1 | Noznesky Justin J | Chief Mktg & Strategy Officer | Open market sale | 6,182 | $38.80 | $239.9K | filing |
| 2026-07-30 | 2026-07-28 | 2 | Doraiswamy Vinayak | Chief Scientific Officer | Open market sale | 6,000 | $38.88 | $233.3K | filing |